Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOCYTOGEN-B

23.800
0.000
Volume:230.50K
Turnover:5.45M
Market Cap:9.51B
PE:258.87
High:24.200
Open:23.800
Low:23.080
Close:23.800
52wk High:31.340
52wk Low:5.600
Shares:399.40M
HK Float Shares:110.78M
Volume Ratio:0.72
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.092
ROE:16.11%
ROA:6.20%
PB:9.77
PE(LYR):258.87
PS:7.32

Loading ...

HK Movers | Biomedical Stocks Jump Again With TransThera Sciences up 30%

Tiger Newspress
·
Oct 17

BIOCYTOGEN-B (02315): A-Share Registration Approved by CSRC

Stock News
·
Oct 16

Biocytogen Pharmaceuticals Receives CSRC Approval for Registration of Proposed A Share Issue on Shanghai Stock Exchange

Reuters
·
Oct 16

Biocytogen Gets Approval to List A Shares on Shanghai's STAR Market; Shares Jump 9%

MT Newswires Live
·
Sep 25

BUZZ-Biocytogen hits record high on green light of Shanghai listing plan

Reuters
·
Sep 25

Hong Kong Stock Alert | BIOCYTOGEN-B (02315) Surges Over 5% Following STAR Board IPO Approval, Recent Partnerships with Merck and Tubulis Advance International Collaboration

Stock News
·
Sep 25

BIOCYTOGEN-B (02315) Receives Approval from Shanghai Stock Exchange STAR Market Listing Committee for Proposed A-Share Issuance

Stock News
·
Sep 24

BIOCYTOGEN-B: From "Thousand Mice, Ten Thousand Antibodies" to Global Partnerships - A Model for Chinese Biotech's International Expansion

Deep News
·
Sep 23

Biocytogen Pharmaceuticals Files Draft Prospectus for A-Share Listing on STAR Market

MT Newswires Live
·
Sep 18

BIOCYTOGEN-B (02315) Technology Platform Yields Multiple Achievements, Signs Consecutive Partnerships with Merck and Tubulis to Advance International Collaboration

Stock News
·
Sep 18

HK Movers | Biotech Stocks Jump With Biocytogen up 11%

Tiger Newspress
·
Sep 18

Hong Kong Stocks Move | BIOCYTOGEN-B (02315) Surges Over 15% in Early Trading as STAR Market IPO Review Approaches, Company Recently Signed Antibody Licensing Deal with Merck

Stock News
·
Sep 18

Hong Kong Stocks Movement | BIOCYTOGEN-B (02135) Surges Over 7% in Afternoon Trading Following New Licensing Deal with Tubulis, After Earlier Merck Collaboration

Stock News
·
Sep 16

Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody

THOMSON REUTERS
·
Sep 16

Hong Kong Stock Movement | BIOCYTOGEN-B (02315) Surges Over 10% After Signing Antibody Option Assessment Agreement with Merck to Advance Antibody-Conjugated Lipid Delivery Solutions

Stock News
·
Sep 15

BRIEF-Biocytogen Enters Into Agreement With Merck To Advance Antibody-Conjugated Lipid-Based Delivery Solutions

Reuters
·
Sep 04

Stock Track | BIOCYTOGEN-B Soars 8.81% Following Strong Interim Results and Technological Advancements

Stock Track
·
Sep 03

Hong Kong Stocks Movement | BIOCYTOGEN-B (02315) Surges Over 5% in Morning Trading on Strong Interim Results, Gene Editing Technology Value Highlighted

Stock News
·
Sep 03

Stock Track | BIOCYTOGEN-B Soars 6.04% Following Strong Mid-Year Financial Results and Industry Recognition

Stock Track
·
Aug 29

Mid-Year Revenue Surges 51.5%: Decoding the Scarcity Value Behind BIOCYTOGEN-B's (02315) Performance

Stock News
·
Aug 29